Monitor for pricing announcement and initial trading volume, as shareholder resale dynamics could influence short-term price action. The lack of new capital suggests this is primarily a liquidity event, not a fundamental growth signal.
Price Chart
Executive Summary
CapsoVision's S-1 registration has become effective, allowing the company to proceed with its IPO. The offering, which includes 2.87 million shares from a prior private placement, is now live, enabling public trading to begin pending pricing and final terms.
Key Facts
- CapsoVision's S-1 registration became effective on April 22, 2026, permitting the company to begin public trading.
- The offering involves resale of 2.87 million shares previously issued in a private placement that raised $14 million.
- This is not a primary capital raise for the company but rather a liquidity event for existing shareholders.
- CapsoVision is a commercial-stage medtech firm focused on capsule endoscopy, with its CapsoCam Plus product generating $13.6 million in 2025 revenue.
Financial Impact
No new capital raised; $14 million previously raised in private placement. Resale of 2.87 million shares may create initial float pressure.
Risk Factors
- Shareholder overhang from resale of 2.87 million shares could pressure the stock post-listing.
- Company faces risks related to FDA approval for next-gen AI-enhanced colon capsule and going concern uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001300 |
| Document: 9999999995-26-001300-index.html | 9999999995-26-001300 |
| Document: 9999999995-26-001300.txt | 9999999995-26-001300 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 28d ago | 8-K | $6.92 | awaiting T+60 | — | $6.99 (+1.01%) |
Sep 28, 2026 28d ago | Press Release | $6.92 | awaiting T+60 | — | $6.99 (+1.01%) |
Sep 23, 2026 4w ago | Insider Cluster | $6.17 | awaiting T+60 | — | $6.99 (+13.29%) |
Sep 22, 2026 4w ago | Institutional Cluster | $6.30 | awaiting T+60 | — | $6.99 (+10.95%) |
Sep 18, 2026 5w ago | 424B5 | $6.70 | awaiting T+60 | — | $6.99 (−4.33%) |
Aug 24, 2026 9w ago | EFFECT | $5.83 | awaiting T+60 | — | $6.99 (−19.90%) |
Aug 13, 2026 10w ago | S-3 | $6.46 | awaiting T+60 | — | $6.99 (−8.20%) |
Jul 21, 2026 13w ago | Insider Buy | $6.91 $6.45 | ▼ −6.66% | ▼ −9.92% | $6.99 (+1.16%) |
Jul 10, 2026 15w ago | Insider Buy | $6.22 $6.50 | ▲ +4.50% | ▲ +0.51% | $6.99 (+12.38%) |
Jul 7, 2026 15w ago | Insider Buy | $6.13 $6.32 | ▲ +3.18% | ▲ +0.69% | $6.99 (+14.12%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers